Evercore ISI raised the firm’s price target on Colgate-Palmolive to $106 from $100 and keeps an Outperform rating on the shares. Expectations for Colgate’s Q2 report are “high but consistent with all data we’ve seen,” says the analyst, who adds in an earnings preview that “conceptually the shares’ premium screens justified on expectations that strong volumes will lift returns even higher.”
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on CL:
- Colgate-Palmolive price target raised to $110 from $100 at BofA
- Colgate-Palmolive price target raised to $112 from $103 at Citi
- Colgate-Palmolive initiated with an Outperform at Exane BNP Paribas
- Colgate-Palmolive Stock (NYSE:CL): Unjustifiably Expensive in Today’s Market
- Colgate-Palmolive named Top Pick in household products at Morgan Stanley